Table. Isolates with elevated MICs for ciprofloxacin and isolates with an MIC for azithromycin above that for wild type (>16 mg/L) in Salmonella enterica serotype Typhi and Paratyphi isolates collected in travelers returning to the Netherlands, 1999–2012.
| Region |
No. (%) isolates |
No. (%) isolates with elevated MICs |
||
| Azithromycin |
Ciprofloxacin |
Azithromycin and ciprofloxacin |
||
| All | 205 | 36 (17.6) | 83 (40.5) | 20 (9.8) |
| Asia | 161 (78.5) | 31 (19.3) | 80 (49.7) | 20 (12.4) |
| Southern Asia* | 84 (40.0) | 21 (25) | 69 (82.1) | 18 (21.4) |
| South-Eastern Asia† | 44 (21.5) | 5 (12.2) | 3 (6.8) | 1 (2.3) |
| Western Asia‡ | 27 (13.2) | 1 (3.7) | 6 (22.2) | 1 (3.7) |
| Eastern Asia§ | 5 (2.4) | 1 (20) | 2 (40) | 0 |
| Unknown | 1 (0.5) | 0 | 0 | 0 |
| Africa¶ | 35 (17.1) | 5 (14.3) | 1 (2.9) | 0 |
| Europe** | 4 (2.0) | 0 | 2 (50) | 0 |
| Latin America†† | 5 (2.4) | 0 | 0 | 0 |
*India, Pakistan, Bangladesh, Nepal, Afghanistan, Nepal, Sri Lanka. †Indonesia, Cambodia, Malaysia, Thailand. ‡Turkey, Iraq, Syria. §China. ¶Morocco, Ghana, Nigeria, Senegal, Tunisia, Malawi, Tanzania. **Gibraltar (Great Britain), Greece, Italy, Romania. ††Peru, Mexico, unknown.